Ticker Details
Glaukos Corporation Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma.
IPO Date:	June 25, 2015
Sector:	Healthcare
Industry:	Medical Instruments and Equipment
Market Cap:	$6.91B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.18 | 2.03%
Avg Daily Range (30 D):	$3.46 | 3.10%
Avg Daily Range (90 D):	$2.36 | 2.31%

Institutional Daily Volume
Avg Daily Volume:	.49M
Avg Daily Volume (30 D):	.76M
Avg Daily Volume (90 D):	.86M

Trade Size
Avg Trade Size (Sh.):	68
Avg Trade Size (Sh.) (30 D):	43
Avg Trade Size (Sh.) (90 D):	48

Institutional Trades
Total Institutional Trades:	6,090
Avg Institutional Trade:	$3.07M
Avg Institutional Trade (30 D):	$4.97M
Avg Institutional Trade (90 D):	$4.89M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.49M
Avg Closing Trade (30 D):	$11.89M
Avg Closing Trade (90 D):	$11.72M
Avg Closing Volume:	61.41K

News

Sep 4, 2025 @ 5:30 AM Nicox prévoit de rembourser intégralement se... Source: Nicox Sa

Sep 4, 2025 @ 5:30 AM Nicox Expects to Fully Repay Financial Debts with ... Source: Gavin Spencer

Sep 11, 2024 @ 6:20 PM Glaukos Stocks Rides on Strong Product Demand Amid... Source: Zacks

Jul 16, 2024 @ 2:30 PM Will WATCHMAN Sales Aid Boston Scientific's (BSX) ... Source: N/A

Jul 16, 2024 @ 2:06 PM Truist lifts Glaukos shares target, highlights str... Source: Emilio Ghigini

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.54	$-.28	$-.34
Diluted EPS	$-1.54	$-.28	$-.34
Revenue	$469.82M	$133.54M	$124.12M
Gross Profit	$361.14M	$104.71M	$97.22M
Net Income / Loss	$-87.61M	$-16.23M	$-19.66M
Operating Income / Loss	$-88.4M	$-16.37M	$-22.69M
Cost of Revenue	$108.68M	$28.83M	$26.9M
Net Cash Flow	$-1.49M	$-8.82M	$-11.56M
PE Ratio